NSE - Free Realtime Quote INR

Hikal Limited (HIKAL.NS)

372.35
-2.35
(-0.63%)
As of 3:22:07 PM GMT+5:30. Market Open.
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
18,435,000
18,435,000
17,687,000
20,047,050
19,260,300
Cost of Revenue
8,373,000
8,373,000
8,247,000
11,422,690
10,332,520
Gross Profit
10,062,000
10,062,000
9,440,000
8,624,360
8,927,780
Operating Expense
8,122,000
8,122,000
7,946,000
7,135,110
6,478,900
Operating Income
1,940,000
1,940,000
1,494,000
1,489,250
2,448,880
Net Non Operating Interest Income Expense
-752,000
-752,000
-564,000
-435,920
-278,260
Pretax Income
1,238,000
1,238,000
955,000
1,053,650
2,185,590
Tax Provision
330,000
330,000
259,000
269,830
580,600
Net Income Common Stockholders
908,000
908,000
696,000
783,820
1,604,990
Diluted NI Available to Com Stockholders
908,000
908,000
696,000
783,820
1,604,990
Basic EPS
7.36
7.36
5.64
6.36
13.02
Diluted EPS
7.36
7.36
5.64
6.36
13.02
Basic Average Shares
123,369.57
123,369.57
123,404.26
123,300.75
123,300.75
Diluted Average Shares
123,369.57
123,369.57
123,404.26
123,300.75
123,300.75
Rent Expense Supplemental
--
--
20,250
25,270
40,680
Total Expenses
16,495,000
16,495,000
16,193,000
18,557,800
16,811,420
Net Income from Continuing & Discontinued Operation
908,000
908,000
696,000
783,820
1,604,990
Normalized Income
908,000
908,000
696,000
780,442.65
1,603,579.95
Interest Income
--
--
16,950
19,560
17,560
Interest Expense
752,000
752,000
564,000
409,330
261,920
Net Interest Income
-752,000
-752,000
-564,000
-435,920
-278,260
EBIT
1,990,000
1,990,000
1,519,000
1,462,980
2,447,510
EBITDA
3,334,000
3,334,000
2,695,000
2,553,110
3,404,200
Reconciled Cost of Revenue
8,373,000
8,373,000
8,247,000
11,422,690
10,332,520
Reconciled Depreciation
1,344,000
1,344,000
1,176,000
1,090,130
956,690
Net Income from Continuing Operation Net Minority Interest
908,000
908,000
696,000
783,820
1,604,990
Total Unusual Items Excluding Goodwill
--
--
5,320
4,540
1,920
Total Unusual Items
--
--
5,320
4,540
1,920
Normalized EBITDA
3,334,000
3,334,000
2,695,000
2,548,570
3,402,280
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
1,162.65
509.95
3/31/2022 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SOLARA.NS Solara Active Pharma Sciences Limited
474.70
+0.39%
 
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,698.50
-0.06%
 
FDC.BO FDC Limited
430.20
-1.05%
 
HKMPF Hikma Pharmaceuticals PLC
27.73
+2.97%
 
WINDLAS.NS Windlas Biotech Limited
917.00
-0.30%
 
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
230.86
-1.26%
 
STAR.NS Strides Pharma Science Limited
779.90
-1.25%
 
LUPIN.NS Lupin Limited
1,996.60
+0.07%
 
PPLPHARMA.NS Piramal Pharma Limited
206.25
-0.88%
 
AARTIDRUGS.NS Aarti Drugs Limited
462.40
-0.18%